The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

We know that chronic heightened stress is not optimal for physical health. A new study looks specifically at how it may ...

Common procedures include endovascular coiling for brain aneurysms, mechanical thrombectomy for acute ischemic stroke, ...

Some people living with chronic stress have a higher risk of stroke, according to a new study. The study looked at younger adults and found an association between stress and stroke, with no known ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...

A new study found that moderate stress levels were associated with a 78% increased risk of stroke in female participants, but ...

Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or ...

Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the standard 60-minute infusion of alteplase.

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...

Discover how smoking and alcohol consumption dramatically increase stroke risk by raising blood pressure, damaging vessels, ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...